2019
DOI: 10.30953/bhty.v2.107
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating Blockchain for the Governance of the Plasma Derivatives Supply Chain: How Distributed Ledger Technology Can Mitigate Plasma Supply Chain Risks

Abstract: This exploratory study examines how distributed ledger technologies could be used within the plasma derivatives supply chain. The plasma derivatives are used increasingly in the pharmaceutical market and the supply chain is global. However, there are significant risks relating to the governance of the supply. The risks include unclear origin of plasma and the propagation of contaminated or poorquality blood to the pharmaceutical production process. From an ethical perspective, the risk is that vulnerable indiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…Donors were recognized through an identifier such as their social security number and password. Besides, Peltoniemi et al [35] discussed how decentralized blockchain was for plasma tracking and management. In more detail, the system stores donors' information before separating their plasma.…”
Section: B Blood Supply Chain Management Systems Based On Blockchain ...mentioning
confidence: 99%
“…Donors were recognized through an identifier such as their social security number and password. Besides, Peltoniemi et al [35] discussed how decentralized blockchain was for plasma tracking and management. In more detail, the system stores donors' information before separating their plasma.…”
Section: B Blood Supply Chain Management Systems Based On Blockchain ...mentioning
confidence: 99%
“…The authors in [33] discussed how the decentralized blockchain can benefit the pharmaceutical supply chain. In particular, they consider the plasma derivatives supply chain as a use case to present their findings.…”
Section: B Blockchain-based Solutionsmentioning
confidence: 99%
“…The proposal is to track the exchange of tokens, called KanCoins, between stakeholders to trace the blood chain. Peltoniemi, Teijo, and Jarkko Ihalainen, in [1], conducted an exploratory study on how distributed ledger technologies could be used within the supply chain of plasma derivatives. It also elucidates the concept of providing incentives to active donors to encourage more voluntary donation.…”
Section: Literature Surveymentioning
confidence: 99%